Stifel reaffirms Buy rating on Outset Medical stock at $17 price target
PositiveFinancial Markets

Stifel has reaffirmed its Buy rating on Outset Medical's stock, setting a price target of $17. This is significant as it reflects confidence in Outset Medical's growth potential and market position, which could attract more investors and positively impact the company's stock performance.
— Curated by the World Pulse Now AI Editorial System